-
Investment type
-
Equity / Class A Common Stock
-
Latest Disclosed Shares Owned
-
6,300,000 shares
-
Security Ownership %
-
6.5%
SymBiosis Capital Partners, LLC ownership in Rani Therapeutics Holdings, Inc. Class A Common Stock
12 Feb 2026 - SymBiosis Capital Partners, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,300,000 shares of Rani Therapeutics Holdings, Inc. Class A Common Stock.
This represents 6.5% ownership of the company.
This is the first filing by SymBiosis Capital Partners, LLC disclosing ownership of Rani Therapeutics Holdings, Inc. Class A Common Stock.